Volume 18, Number 12—December 2012
Research
Diagnostic Assays for Crimean-Congo Hemorrhagic Fever
Table 3
Patient characteristics and sample storage information for samples tested for CCHFV
CCHFV positive, n = 66 | CCHFV negative, n = 73 | CCHFV positive, n = 54 | CCHFV negative, n = 21 | ||
---|---|---|---|---|---|
Conditions | |||||
CCHF |
66 (100.0) | 0 | 54 (100.0) | 0 | |
Brucellosis |
0 | 2 (2.7) | 0 | 2 (9.5) | |
Chikungunya |
0 | 1 (1.4) | 0 | 1 (4.8) | |
HFRS |
0 | 13 (17.8) | 0 | 7 (33.3) | |
Leptospirosis |
0 | 13 (17.8) | 0 | 3 (14.3) | |
Q fever |
0 | 1 (1.4) | 0 | 1 (4.8) | |
Tularemia |
0 | 1 (1.4) | 0 | 1 (4.8) | |
West Nile fever |
0 | 1 (1.4) | 0 | 1 (4.8) | |
Healthy or non-CCHF |
0 | 41 (56.2) | 0 | 5 (23.8) | |
Patient country of origin | |||||
Albania |
9 (13.6) | 0 | 8 (14.8) | 0 | |
Germany |
0 | 23 (31.5) | 0 | 7 (33.3) | |
Greece |
0 | 9 (12.3) | 0 | 9 (42.9) | |
Iran |
32 (48.5) | 0 | 31 (57.4) | 0 | |
Kosovo |
21 (31.8) | 20 (27.4) | 7 (13.0) | 4 (19.0) | |
Portugal |
0 | 20 (27.4) | 0 | 0 | |
Sub-Saharan Africa |
4 (6.1) | 0 | 0 | 0 | |
Turkey |
0 | 1 (1.4) | 8 (14.8) | 1 (4.8) | |
CCHF disease severity | |||||
Moderate |
49 (74.2) | 0 | 37 (68.5) | 0 | |
Severe |
11 (16.7) | 0 | 2 (3.7) | 0 | |
Fatal |
3 (4.5) | 0 | 6 (11.1) | 0 | |
Asymptomatic |
3 (4.5) | 0 | 7 (13.0) | 0 | |
Unknown |
0 | 0 | 2 (3.7) | 0 | |
Length of illness, d | |||||
<15 d |
46 (69.7) | 0 | 43 (79.6) | 0 | |
≥15 d |
12 (18.2) | 0 | 0 | 0 | |
Asymptomatic |
3 (4.5) | 0 | 7 (13.0) | 0 | |
Unknown |
5 (7.6) | 0 | 4 (7.4) | 0 | |
Sample storage time, y | |||||
<10 |
49 (74.2) | 64 (87.7) | 54 (100.0) | 10 (47.6) | |
≥10 |
17 (25.8) | 0 | 0 | 2 (9.5) | |
Unknown |
0 | 9 (12.3) | 0 | 9 (42.9) | |
Sample storage temperature, °C | |||||
−80 |
34 (51.5) | 49 (67.1) | 9 (16.7) | 4 (19.1) | |
−70 |
32 (48.5) | 0 | 45 (83.3) | 9 (42.9) | |
−20 |
0 | 24 (32.9) | 0 | 8 (38.1) |
*CCHF, Crimean-Congo hemorrhagic fever; CCHFV, CCHF virus; HFRS, hemorrhagic fever with renal syndrome.